These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24727895)

  • 41. Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.
    Ge GZ; Xu TR; Chen C
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):477-87. PubMed ID: 26040315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.
    West KA; Brognard J; Clark AS; Linnoila IR; Yang X; Swain SM; Harris C; Belinsky S; Dennis PA
    J Clin Invest; 2003 Jan; 111(1):81-90. PubMed ID: 12511591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung.
    Hong JY; Wang ZY; Smith TJ; Zhou S; Shi S; Pan J; Yang CS
    Carcinogenesis; 1992 May; 13(5):901-4. PubMed ID: 1587006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
    Schrader E; Hirsch-Ernst KI; Richter E; Foth H
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):336-43. PubMed ID: 9550307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
    Atalla A; Maser E
    Toxicology; 1999 Nov; 139(1-2):155-66. PubMed ID: 10614696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate.
    Staretz ME; Foiles PG; Miglietta LM; Hecht SS
    Cancer Res; 1997 Jan; 57(2):259-66. PubMed ID: 9000565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung.
    Ashmore JH; Luo S; Watson CJW; Lazarus P
    Carcinogenesis; 2018 Jul; 39(8):1079-1088. PubMed ID: 29788210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17.
    Kennedy CL; Najdovska M; Jones GW; McLeod L; Hughes NR; Allison C; Ooi CH; Tan P; Ferrero RL; Jones SA; Dev A; Sievert W; Bhathal PS; Jenkins BJ
    J Pathol; 2011 Oct; 225(2):255-64. PubMed ID: 21710691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.
    Ruwanpura SM; McLeod L; Brooks GD; Bozinovski S; Vlahos R; Longano A; Bardin PG; Anderson GP; Jenkins BJ
    Respirology; 2014 Apr; 19(3):419-27. PubMed ID: 24506702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Aizawa K; Liu C; Veeramachaneni S; Hu KQ; Smith DE; Wang XD
    Lung Cancer; 2013 Dec; 82(3):390-6. PubMed ID: 24396883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
    Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG
    Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of gp130 expression by the mitogen-activated protein kinase ERK2.
    Bonito NA; Drechsler J; Stoecker S; Carmo CR; Seckl MJ; Hermanns HM; Costa-Pereira AP
    Oncogene; 2014 Apr; 33(17):2255-63. PubMed ID: 23686311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate.
    Hecht SS; Trushin N; Rigotty J; Carmella SG; Borukhova A; Akerkar S; Rivenson A
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):645-52. PubMed ID: 8824368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
    Fang XX; Jiang XL; Han XH; Peng YP; Qiu YH
    Cell Mol Neurobiol; 2013 Mar; 33(2):241-51. PubMed ID: 23161148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation.
    Min HY; Boo HJ; Lee HJ; Jang HJ; Yun HJ; Hwang SJ; Smith JK; Lee HJ; Lee HY
    Oncotarget; 2016 Oct; 7(43):70936-70947. PubMed ID: 27708216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Jalas JR; McIntee EJ; Kenney PM; Upadhyaya P; Peterson LA; Hecht SS
    Chem Res Toxicol; 2003 Jun; 16(6):794-806. PubMed ID: 12807363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
    Li MY; Hsin MK; Yip J; Mok TS; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):113-22. PubMed ID: 19346318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways.
    Shin VY; Jin HC; Ng EK; Yu J; Leung WK; Cho CH; Sung JJ
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):254-61. PubMed ID: 18805435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model.
    Kim Y; Chongviriyaphan N; Liu C; Russell RM; Wang XD
    Carcinogenesis; 2006 Jul; 27(7):1410-9. PubMed ID: 16401635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis.
    Li MY; Liu LZ; Li W; Ng CSH; Liu Y; Kong AWY; Zhao Z; Wang S; Qi H; Jia H; Yang S; Du J; Long X; Ho RLK; Chak ECW; Wan IYP; Mok TSK; Underwood MJ; Gali NK; Ning Z; Chen GG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):359. PubMed ID: 31420013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.